EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Statistically Optimized Tacrolimus and Thymoquinone Co-Loaded Nanostructured Lipid Carriers Gel for Improved Topical Treatment of Psoriasis

Meraj Alam, Md Rizwanullah iD, Showkat R Mir, Saima Amin

Gels · 25.06.2023 · 9 (7) · 515

DOI: 10.3390/gels9070515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gels, online erschienen am 25.06.2023. Verfasst von Meraj Alam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council of Scientific Industrial Research (CSIR), Government of India, Jamia Hamdard, Concord Biotech Limited, Gujarat, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this investigation was to develop and analyze a tacrolimus and thymoquinone co-loaded nanostructured lipid carriers (TAC-THQ-NLCs)-based nanogel as a new combinatorial approach for the treatment of psoriasis. The NLCs were formulated by an emulsification-solvent-evaporation technique using glyceryl monostearate, Capryol 90 (oil), and a mixture of Tween 80 and Span 20 as a solid lipid, liquid lipid, and surfactant, respectively. Their combination was optimized using a three-factor and three-level Box–Behnken design (33-BBD). The optimized TAC-THQ-NLCs were observed to be smooth and spherical with a particle size of 144.95 ± 2.80 nm, a polydispersity index of 0.160 ± 0.021, a zeta potential of −29.47 ± 1.9 mV, and an entrapment efficiency of >70% for both drugs. DSC and PXRD studies demonstrated the amorphous state of TAC and THQ in the lipid matrix of the NLCs. An FTIR analysis demonstrated the excellent compatibility of the drugs with the excipients without interactions. The TAC-THQ-NLC-based nanogel (abbreviated as TAC-THQ-NG) exhibited a good texture profile and good spreadability. The in vitro release study demonstrated a sustained drug release for 24 h from the TAC-THQ-NG that followed the Korsmeyer–Peppas kinetic model with a Fickian diffusion mechanism. Moreover, the TAC-THQ-NG revealed significantly higher dose-dependent toxicity against an HaCaT cell line compared to a TAC-THQ suspension gel (abbreviated as TAC-THQ-SG). Furthermore, the developed formulations demonstrated antioxidant activity comparable to free THQ. Confocal microscopy revealed improved permeation depth of the dye-loaded nanogel in the skin compared to the suspension gel. Based on these findings, it was concluded that TAC-THQ-NG is a promising combinatorial treatment approach for psoriasis.

Schlagwörter

Stichwörter der Autor:innen

Box–Behnken designnanostructured lipid carrierpsoriasistacrolimusthymoquinonetopical delivery

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.
  • Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.

ORCID-Profile: Md Rizwanullah

Förderung

  • Council of Scientific Industrial Research (CSIR), Government of India
  • Jamia Hamdard
  • Concord Biotech Limited, Gujarat, India

Zitieren

APA

Alam, M., Rizwanullah, M., Mir, S. R., & Amin, S. (2023). Statistically Optimized Tacrolimus and Thymoquinone Co-Loaded Nanostructured Lipid Carriers Gel for Improved Topical Treatment of Psoriasis. Gels, 9(7), 515. https://doi.org/10.3390/gels9070515

Vancouver

Alam M, Rizwanullah M, Mir SR, Amin S. Statistically Optimized Tacrolimus and Thymoquinone Co-Loaded Nanostructured Lipid Carriers Gel for Improved Topical Treatment of Psoriasis. Gels. 2023;9(7):515. doi:10.3390/gels9070515

BibTeX
@article{Alam2023,
  author = {Alam, Meraj and Rizwanullah, Md and Mir, Showkat R and Amin, Saima},
  title = {Statistically Optimized Tacrolimus and Thymoquinone Co-Loaded Nanostructured Lipid Carriers Gel for Improved Topical Treatment of Psoriasis},
  journal = {Gels},
  year = {2023},
  volume = {9},
  number = {7},
  pages = {515},
  doi = {10.3390/gels9070515}
}
Kostenlos starten →